IMPAX LABORATORIES INC's ticker is IPXL and the CUSIP is 45256B101. A total of 190 filers reported holding IMPAX LABORATORIES INC in Q1 2018. The put-call ratio across all filers is 0.13 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $5,000 | -16.7% | 272 | 0.0% | 0.00% | – |
| Q3 2017 | $6,000 | +50.0% | 272 | 0.0% | 0.00% | – |
| Q2 2017 | $4,000 | -99.7% | 272 | -99.8% | 0.00% | -100.0% |
| Q1 2017 | $1,497,000 | -4.5% | 118,327 | 0.0% | 0.01% | 0.0% |
| Q4 2016 | $1,568,000 | -61.6% | 118,327 | -31.3% | 0.01% | -59.4% |
| Q3 2016 | $4,082,000 | -16.7% | 172,237 | +1.3% | 0.03% | -23.8% |
| Q2 2016 | $4,901,000 | -10.0% | 170,057 | 0.0% | 0.04% | -19.2% |
| Q1 2016 | $5,445,000 | -28.3% | 170,057 | -4.2% | 0.05% | -28.8% |
| Q4 2015 | $7,589,000 | +17.6% | 177,473 | -3.2% | 0.07% | +7.4% |
| Q3 2015 | $6,452,000 | -23.7% | 183,256 | -0.5% | 0.07% | -34.6% |
| Q2 2015 | $8,461,000 | -2.0% | 184,265 | 0.0% | 0.10% | +6.1% |
| Q1 2015 | $8,636,000 | +35.4% | 184,265 | -8.4% | 0.10% | +34.2% |
| Q4 2014 | $6,376,000 | – | 201,240 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Orbimed Advisors | 5,415,600 | $162,414,000 | 1.91% |
| Broadfin Capital, LLC | 1,217,858 | $36,524,000 | 1.80% |
| NEW AMSTERDAM PARTNERS LLC/NY | 695,100 | $20,846,000 | 1.36% |
| Healthcare Value Capital, LLC | 50,000 | $1,500,000 | 1.26% |
| Iguana Healthcare Management, LLC | 75,000 | $2,249,000 | 1.05% |
| Matarin Capital Management, LLC | 78,292 | $2,347,977,000 | 1.04% |
| Independence Capital Asset Partners, LLC | 253,089 | $7,590,000 | 1.04% |
| Tekla Capital Management LLC | 344,683 | $10,337,000 | 0.95% |
| Penn Capital Management Company, LLC | 794,641 | $23,831,000 | 0.92% |
| Leonard Capital Management, Inc. | 87,661 | $2,629,000 | 0.89% |